Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Jan;27(1):55–59. doi: 10.1128/aac.27.1.55

In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs.

C J Gebhart, G E Ward, H J Kurtz
PMCID: PMC176204  PMID: 3985597

Abstract

The in vitro activities of 47 antimicrobial agents against 30 isolates of Campylobacter species from pigs were determined by the agar dilution technique. The isolates were obtained from pigs with proliferative enteritis and included 10 strains each of Campylobacter coli, Campylobacter sputorum subsp. mucosalis, and "Campylobacter hyointestinalis Gebhart et al." (this name is not on the Approved Lists). Carbadox, furazolidone, nitrofurantoin, gentamicin, and dimetridazole were the most active drugs, inhibiting all three Campylobacter species with a MIC for 50% of the isolates of 2 micrograms/ml or less. Trimethoprim-sulfamethoxazole, cefazolin, sulfachloropyridazine, novobiocin, vancomycin, sulfathiazole, cyclohexamide, bacitracin, p-arsanilic acid, and colistin were the least active, with MICs for 50% of the isolates ranging from 16 to greater than or equal to 128 micrograms/ml.

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahonkhai V. I., Cherubin C. E., Sierra M. F., Bokkenheuser V. D., Shulman M. A., Mosenthal A. C. In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents. Antimicrob Agents Chemother. 1981 Dec;20(6):850–851. doi: 10.1128/aac.20.6.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Butzler J. P., Dekeyser P., Lafontaine T. Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother. 1974 Jan;5(1):86–89. doi: 10.1128/aac.5.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chow A. W., Patten V., Bednorz D. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother. 1978 Mar;13(3):416–418. doi: 10.1128/aac.13.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gebhart C. J., Ward G. E., Chang K., Kurtz H. J. Campylobacter hyointestinalis (new species) isolated from swine with lesions of proliferative ileitis. Am J Vet Res. 1983 Mar;44(3):361–367. [PubMed] [Google Scholar]
  5. Karmali M. A., De Grandis S., Fleming P. C. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother. 1980 Dec;18(6):948–951. doi: 10.1128/aac.18.6.948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Karmali M. A., De Grandis S., Fleming P. C. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother. 1981 Apr;19(4):593–597. doi: 10.1128/aac.19.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lawson G. H., Rowland A. C. Intestinal adenomatosis in the pig: a bacteriological study. Res Vet Sci. 1974 Nov;17(3):331–336. [PubMed] [Google Scholar]
  8. Love R. J., Love D. N. Control of proliferative haemorrhagic enteropathy in pigs. Vet Rec. 1977 May 28;100(22):473–473. doi: 10.1136/vr.100.22.473. [DOI] [PubMed] [Google Scholar]
  9. Michel J., Rogol M., Dickman D. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother. 1983 May;23(5):796–797. doi: 10.1128/aac.23.5.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rowland A. C., Lawson G. H. Intestinal adenomatosis in the pig: immunofluorescent and electron microscopic studies. Res Vet Sci. 1974 Nov;17(3):323–330. [PubMed] [Google Scholar]
  11. Secker D. A. Erythromycin resistance only found in Campylobacter coli. J Antimicrob Chemother. 1983 Oct;12(4):414–415. doi: 10.1093/jac/12.4.414. [DOI] [PubMed] [Google Scholar]
  12. Shanker S., Sorrell T. C. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology. 1983 Jan;15(1):61–63. doi: 10.3109/00313028309061403. [DOI] [PubMed] [Google Scholar]
  13. Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Spelhaug D. R., Gilchrist M. J., Washington J. A., 2nd Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis. J Infect Dis. 1981 Mar;143(3):500–500. doi: 10.1093/infdis/143.3.500. [DOI] [PubMed] [Google Scholar]
  15. Svedhem A., Kaijser B., Sjögren E. Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens. J Antimicrob Chemother. 1981 Mar;7(3):301–305. doi: 10.1093/jac/7.3.301. [DOI] [PubMed] [Google Scholar]
  16. Tally F. P., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother. 1975 May;7(5):672–675. doi: 10.1128/aac.7.5.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Vanhoof R., Goossens H., Coignau H., Stas G., Butzler J. P. Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother. 1982 Jun;21(6):990–992. doi: 10.1128/aac.21.6.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vanhoof R., Gordts B., Dierickx R., Coignau H., Butzler J. P. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother. 1980 Jul;18(1):118–121. doi: 10.1128/aac.18.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Walder M., Forsgren A. Erythromycin-resistant Campylobacters. Lancet. 1978 Dec 2;2(8101):1201–1201. doi: 10.1016/s0140-6736(78)92182-7. [DOI] [PubMed] [Google Scholar]
  21. Walder M. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother. 1979 Jul;16(1):37–39. doi: 10.1128/aac.16.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES